TABLE 2. Defined daily doses per 1,000 inhabitant-days for parenteral antibiotics purchased by hospitals in Canada, 2001–2011.
| ATC1 Class and antimicrobial | DDDs2/1,000 inhabitant-days | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | ||
| I3 |
β-lactamase inhibitors (J01CR) Piperacillin and enzyme inhibitor, ticarcillin and enzyme inhibitor |
0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
|
Third-generation cephalosporins (J01DD) Cefotaxime, ceftazidime, ceftizoxime, ceftriaxone |
0.03 | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.07 | 0.08 | 0.07 | 0.08 | |
|
Fourth-generation cephalosporins (J01DE) Cefepime, ceftobiprole |
< 0.01 | < 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | |
|
Carbapenems (J01DH) Doripenem, ertapenem, imipenem, meropenem |
0.01 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
|
Fluoroquinolones (J01MA) Ofloxacin, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin |
0.05 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | |
|
Glycopeptides (J01XA) Vancomycin |
0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
|
Imidazole (J01XD) Metronidazole |
0.06 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| II |
Penicillins with extended spectrum (J01CA) Ampicillin, pivampicillin |
0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 |
|
β-lactamase sensitive penicillins (J01CE) Penicillin G |
0.21 | 0.19 | 0.22 | 0.27 | 0.28 | 0.28 | 0.26 | 0.27 | 0.26 | 0.25 | 0.25 | |
|
β-lactamase resistant penicillins (J01CF) Cloxacillin |
0.05 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | |
|
First-generation cephalosporins (J01DB) Cefazolin, cephalothin |
0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 | 0.12 | 0.13 | 0.12 | 0.12 | |
|
Second-generation cephalosporins (J01DC) Cefotetan, cefoxitin, cefuroxime |
0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | < 0.01 | < 0.01 | |
|
Macrolides (J01FA) Azithromycin, erythromycin |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
|
Lincosamides (J01FF) Clindamycin |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
|
Aminoglycosides (J01GB) Amikacin, gentamicin, netilmicin, tobramycin |
0.06 | 0.05 | 0.03 | 0.02 | 0.03 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | |
| Total (J01) | 0.78 | 0.76 | 0.76 | 0.77 | 0.79 | 0.83 | 0.80 | 0.79 | 0.82 | 0.77 | 0.79 | |
1 ATC = Anatomical Therapeutic Chemical 2 DDDs = defined daily doses 3 Roman numerals I and II indicate the ranking of antibiotics based on importance in human medicine as outlined by the Veterinary Drugs Directorate.